World Leader in

Cell Expansion & Rejuvenation

What
We do

EnhanceTM
Platform

Proprietary hematopoietic stem cell (HSC) expansion and rejuvenation platform

Learn more

UM171 Cell
Therapy

Allogeneic stem cell therapy to treat blood cancers

Learn more

Pipeline

Pre-clinical pipeline for blood cancers and other diseases

Learn more

News

November 9, 2026

Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Europe

Partnership advances the global commercialization strategy for Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, following its conditional marketing authorisation in Europe from the European Commission. Exclusive licensing and supply agreements grant Avanzanite commercialization rights for Zemcelpro® across 32 countries covering the European Economic Area, the United Kingdom and Switzerland. MONTREAL, November 9, 2026 – ExCellThera […]

Read more
See all articles

About us

Who we are

ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases.

Learn more
Symbol